Docosahexaenoic acid for treating subclinical inflammation
摘要
<p>This invention is directed to methods and compositions which impede the development and progression of diseases associated with subclinical inflammation. Subclinical inflammation is commonly associated with atherosclerotic cardiovascular disease, coronary disease or cerebrovascular disease. The methods and compositions of the invention are also particularly suited to providing therapy for subclinical inflammation in diabetic and prediabetic patients. Methods of the invention comprise administration of DHA alone and in combination with antiplatelet drugs.</p>
申请公布号
EP2283838(A2)
申请公布日期
2011.02.16
申请号
EP20100179837
申请日期
2003.09.29
申请人
MARTEK BIOSCIENCES CORPORATION
发明人
ARTERBURN, LINDA, M;HOFFMAN, JAMES, P;OKEN, HARRY, A;VAN ELSWYK, MARY